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osting by EAbstract Background/aims: To study the changes in wavefront (ocular) and corneal higher order
aberrations (HOAs) and visual acuity (VA) outcome following wavefront-guided advanced surface
ablation (ASA) techniques and intralase femtosecond LASIK (iLASIK) in myopia treatment.
Methods: Ocular aberration and corneal topography of 240 eyes in the ASA techniques (this was
equally divided into a ﬂap-on group where the epithelial ﬂap was preserved and reapplied to the
photoablated stromal bed and a ﬂap-off group when the epithelial ﬂap was discarded during the
procedure), and 138 eyes in the iLASIK group were obtained before and 3 months following treat-
ment. The correlation of aberrations with best spectacle-corrected visual acuity was analyzed.
Results: At 3 months, there was statistically signiﬁcant (P< 0.001) surgically induced increase in
spherical aberration (SA) in each of the techniques for both ocular and corneal analysis. iLASIK
induced signiﬁcantly less ocular and corneal HOAs (P< 0.001). The mean manifest refractive
spherical equivalent was closer to attempted correction compared to other groups (P< 0.001).ted Arab Emirates University,
es, P.O. Box 17666, Al Ain,
37580; fax: +971 3 7672067.
(T. AlMahmoud).
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276 T. AlMahmoud et al.Eighty-three eyes (70%) of ﬂap-on, 80 (67%) ﬂap-off and 94 eyes (68%) in the iLASIK group
achieved 20/20 uncorrected VA. Fifteen eyes (11%) accomplished 20/12.5 or better in iLASIK com-
pared to 4 (3%) for ﬂap-on and 7 (6%) for ﬂap-off ASA group. Only the ﬂap-off treatment showed
a consistent correlation between the corrected aberrations and visual performance.
Conclusion: At 3 months, all procedures resulted in a signiﬁcant increase in HOAs and SA. All had
comparable 20/20 VA and 11% of iLASIK patients achieved 20/12.5 or better level.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Two approaches to refractive error correction have been
developed: laser assisted in situ keratomileusis (LASIK) and
surface ablation [epithelial ﬂap-on procedures, such as laser
assisted subepithelial keratomileusis (LASEK), epikeratome
laser assisted in situ keratomileusis (Epi-LASIK) and epithelial
ﬂap-off such as epikeratome photorefractive keratectomy
(Epi-PRK), and alcohol assisted photorefractive keratectomy
(AA-PRK)].
Despite newer techniques and better equipment, there is still
reported ﬁnding of increased higher order aberrations (HOAs)
even with the use of wavefront-guided (WF) ablations (Kalyvia-
naki et al., 2008; McAlinden andMoore, 2010). Poor postoper-
ative quality of vision with an increase in HOAs has been
reported (Sharma et al., 2007). Some surgeons feel that surface
ablation provides better quality of vision and less dry eye and in-
duces fewerHOAs than LASIK (Chung etal., 2006; Hersh etal.,
1998; Randleman et al., 2007). Also the superiority of surface
ablation seems to stem from awareness of iatrogenic corneal
ectasia seen mostly after LASIK (Binder, 2007; Randleman,
2006). However, more recently there is evidence that the femto-
second laser has the ability to create planar ﬂaps, induce less
ocular HOAs and reduce the incidence of ﬂap-related complica-
tions with less variability in ﬂap thickness compared to mechan-
ical microkeratomes (Binder, 2004; Medeiros et al., 2007;
Solomon et al., 2004; Talamo et al., 2006).
Our earlier work showed no signiﬁcant difference in the in-
duced ocular or corneal spherical aberration (SA), HOAs and
coma aberrations between LASEK and Epi-LASIK nor when
compared Epi-PRK to AAPRK. However, a difference was
observed when any single procedure in the ﬂap-off to ﬂap-on
group was compared (AlMahmoud et al., 2011). Also studies
have cited comparable results for visual or refractive outcome
at 3 months between Epi-LASIK and LASEK (Hondur et al.,
2008; Teus et al., 2008) and thus we found that it would be rea-
sonable to group the ASA procedures into ﬂap-on and off.
We are not aware of the previously published reports com-
paring epithelial ﬂap-on and epithelial ﬂap-off advanced sur-
face ablations (ASA) techniques to intralase femtosecond
LASIK (iLASIK) with detailed analysis of both ocular and
corneal HOAs.
2. Materials and methods
In a retrospective study approved by the Research Ethics
Board of the Ottawa Hospital Research Institute, ocular wave-
front aberration [WaveScan WaveFront System, Abbott
Medical Optics Inc. (AMO)] and corneal topography
[Pentacam, Oculus (Oculus, Wetzlar, Germany)] of 378 eyes
were obtained before and 3 months following treatment.
Two hundred and forty eyes and were equally divided betweenthe four ASA techniques (Epi-LASIK, LASEK, Epi-PRK, and
AA-PRK), matched for mean and range of manifest refraction
(these datasets used here originated from an earlier study)
(AlMahmoud et al., 2011) and 138 consecutive eyes that
underwent iLASIK. The range of spherical correction was
1.00 to 8.25 D and 1.00 to 9.5 for ASA and iLASIK,
respectively. Corneal wavefront aberrations were calculated
by ray-tracing from elevation maps using the Advanced
Custom Ablation Planer (ACAP) software from AMO after
registration of the corneal maps at the pupil center using the
corneal apex to pupil center offset provided by the WaveScan
aberrometer. Corneal and ocular aberrations were expressed
over a 5 mm pupil diameter. The ASA cohort was categorized
into ﬂap-on procedures (120 eyes) where it included all eyes
with preserved epithelial ﬂap (Epi-LASIK and LASEK) and
ﬂap-off (120 eyes) where the epithelial ﬂaps were discarded in-
tra-operatively (Epi-PRK and AA-PRK), procedure detail in
press (AlMahmoud et al., 2011).
Procedures were performed under topical anesthesia with 3
drops of proparacaine hydrochloride 0.5% (Alcaine, Alcon)
over a 10 min period. Patients underwent correction for myo-
pia, with or without astigmatism, using WF VISX STAR S4
IR (AMO, Santa Ana, USA). This system uses a scanning
spot excimer laser with variable spot size and shape beam
(0.65–6.5 mm), active tracker, and Iris registration function.
All had Fourier WF ablation to achieve emmetropia and a
6–8% nomogram adjustment was used in the ASA group.
0.02% Mitomycin C was applied to the stromal bed in the
ASA cohort for 15–30 s to the eyes with spheres of 6.00 D
or more or cylinder of more than 2.00 D.
In the iLASIK group, the attempted ﬂap thickness was
110 lm and 8.7 mm diameter, using intralase femtosecond la-
ser [(IntraLase FS Laser) (60-kHz; Abbott Medical Optics
Inc. (AMO), Santa Ana, USA)]. A raster pattern was used
with the hinge located in the superior position with the raster
energy of 1.15 lJ/spot and spot line separation of 8 · 8 lm.
The hinge angle was set at 55 and the side-cut angle was
70 and the pocket software was enabled.
Immediately after completion of surgery, all patients
received moxiﬂoxacin 0.5% (Vigamox Ophthalmic Solution,
Alcon) and continued 4 times/day for 1 week. The iLASIK pa-
tients received sandoz prednisolone 1% (prednisolone acetate;
Sandoz) four times daily for the ﬁrst 7 days, as well as the arti-
ﬁcial tears. The steroid was tapered to three times daily in the
second week, twice daily in the third week, and then to once
daily for the last week. In ASA group postoperatively, a
bandage contact lens 0.50 D with a base curve of 8.6 (Shine
Optical, Netherlands) was placed on the eyes that received
treatment and left in place until the corneal epithelialization
was complete. The ASA cohorts received dexamethasone
0.1% (Maxidex Ophthalmic Suspension, Alcon) six times daily
for the ﬁrst postoperative week followed by ﬂuorometholone
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day for 2 months and then tapered over another 4 weeks and
artiﬁcial tears as required. These patients also received
ketorolac 0.5% (Acular LS, Allergan) four times daily for
24 h, and acetaminophen/codeine phosphate (TYLENOL
with Codeine) 1 tablet 4–6 times daily for pain control.
iLASIK patients were seen at 1 and 3 days; 1 week; and 1,
3, 6 and 12 months after surgery. Patients in the ASA group
were seen daily for the ﬁrst week, then 1, 2, 3, 6 and 12 months
postoperatively. All eyes were assessed preoperative and post-
operative for uncorrected distance visual acuity (UDVA), and
best spectacle-corrected distance visual acuity (CDVA) using
Snellen chart. A detailed and systematic recording of visual
acuity was followed with documentation of up to a single loss
or gain of a letter in a given line, for example, 20/12.5+1 (i.e.,
all the letters on line 12.5 were seen plus one on next line) or
20/12.51 (i.e., one letter was not seen on that line).
Datasets that passed the normality test (Shapiro–Wilkes)
are presented as mean ± standard deviation (SD). The data
that failed the normality test are presented as median [25, 75
conﬁdence intervals (CI)]. Root-mean-square (RMS) wave-
front error was used as global optical quality metric. All values
and group comparisons were performed using One Way Anal-
ysis of Variance (ANOVA) and within group comparisons
using paired t-tests. Correlations were performed using
Pearson Correlations. Visual acuity was compared by the log-
arithm of the minimum angle of resolution with expression
unit of minutes of arc (min. arc). In addition, changes in the
HOAs and it’s predictability of the visual and refractive out-
come were evaluated. A P value of 0.05 or less was considered
to be statistically signiﬁcant for all analyses.3. Results
There were no statistically signiﬁcant differences between ﬂap-
on, ﬂap-off ASA and iLASIK groups in the mean preoperative
refractive spherical equivalent ± SD (4.06 ± 1.93, 4.02 ±
1.98, and 3.79 ± 1.95 D, respectively), in the mean preoper-
ative refractive cylinder power (0.50 ± 0.54, 0.61 ± 0.50, and
0.69 ± 0.66 D, respectively), nor in the mean age at the time of
the treatment (34 ± 8.7, 34 ± 9, and 40 ± 9.0 years, respec-
tively) (Table 1).
3.1. Snellen visual acuity
The mean preoperative UDVA was 20/320 for either ﬂap-on or
ﬂap-off ASA and 20/2502 in the iLASIK (logmar 1.13 ± 0.52
vs. 1.20 ± 0.44), ranging from 20/30 to 20/320+2, 20/30+2 to
20/320+2 and 20/30+2 to 20/800, respectively. The mean preop-
erative CDVA was 20/16 in iLASIK (range, 20/25+1 to 20/15)
and 20/20+1 in ﬂap-on group (range, 20/16 to 20/30), ﬂap-off
20/20+1 (range, 20/16 to 20/30) (logmar 0.03 ± 0.05, 0.03
± 0.06 vs. 0.03 ± 0.05).
At 3 months postoperatively, 70% of the ﬂap-on eyes, 67%
ﬂap-off and 68% in the iLASIK group had UDVA of 20/20 or
better. However, in iLASIK more eyes achieved UDVA of 20/
12.5 or better (11%) compared to other groups (3% ﬂap-on
and 6% ﬂap-off ASA) (Fig. 1). We found 98% of ﬂap-on
and iLASIK eyes obtained 20/40 UDVA, while all eyes from
ﬂap-off group achieved that. The mean CDVA was 20/20+2
for ﬂap-on and 20/162 for ﬂap-off as well as iLASIK grouppostoperatively. There was no signiﬁcant difference between
the groups UDVA or CDVA postoperatively.
Ten eyes (8%) in the ﬂap-on andnon in the ﬂap-off group lost
one line compared to two eyes (1.5%) in the iLASIK group and
no eyes lost more than one line of CDVA (Fig. 2). On the other
hand 18% (22/120) gained one line of CDVA in the ﬂap-on,
23% (28/120) ﬂap-off and 16% (22/136) in the iLASIK group
(Fig. 2).
3.2. Mean manifest refraction spherical equivalent (MRSE)
One hundred and fourteen (95%) eyes in the ﬂap-on group,
118 (98%) eyes in the ﬂap-off and 114 (86%) in the iLASIK
had a postoperative MRSE within ±0.50 D. Two hundred
and forty (100%) in both ﬂap-on or off and 126 eyes (95%)
in the iLASIK were within ±1.00 D. All eyes were within
±2.00 D of attempted correction at 3 months postoperative.
The iLASIK had postoperative MRSE closer to the emmetro-
pia (P< 0.001) and tighter SD compared to ﬂap-on or ﬂap-off
ASA groups (0.14 ± 0.43, 0.62 ± 0.97 and 0.53 ± 0.81,
respectively).
3.3. Wavefront (ocular) higher order aberrations
In both the ﬂap-on and ﬂap-off groups, there was a signiﬁcant
increase in ocular HOAs, SA and coma values at 3 months post-
operatively (P< 0.001). However, the iLASIK group showed
only statistically signiﬁcant increase in SA (P< 0.001). Pairwise
multiple comparison procedures (Dunn’s method) identiﬁed a
difference between the groups with iLASIK inducing signiﬁ-
cantly lower HOAs and SA compared to ﬂap-on or off group
(P< 0.001). On the other hand, there was no statistical signiﬁ-
cant difference between the iLASIK and ASA group for the in-
duced coma (P= 0.857) (Table 2).
3.4. Corneal higher order aberrations
Postoperatively in each of the groups (total ASA, ﬂap-on, ﬂap-
off ASA and iLASIK) there was a statistically signiﬁcant
induction of corneal HOA, SA and coma from the preop value
to 3 months postprocedure (ANOVA, P< 0.001). Pairwise
multiple comparison procedures (Dunn’s method) identiﬁed
a difference between the groups with HOAs being signiﬁcantly
lower in iLASIK compared to ASA ﬂap-on or ﬂap-off groups
(P< 0.001). Also, there was statistically signiﬁcant lower
induction of SA in the iLASIK compared to the ﬂap-off group
(P= 0.050). Regarding coma, iLASIK induced signiﬁcantly
more compared to the ﬂap-on group (P= 0.017) (Table 3).
3.5. Correlation between changes in aberration and CDVA
postoperatively
Surgically induced corneal aberrations were signiﬁcantly corre-
lated to the changes in CDVA following surgery in the ﬂap-off
ASA for HOA, SA and coma (0.250, P= 0.006), (0.247,
P= 0.007) and (0.180, P= 0.051), respectively. On the
other hand, the ﬂap-on subgroup did not show any signiﬁcant
correlation for previous parameters while iLASIK group iden-
tiﬁed signiﬁcant correlation only for corneal SA (0.194,
P= 0.025).
Flap-off ASA also showed signiﬁcant correlation between
change in ocular aberrations and change in CDVA following






































P valuea 0.414 0.691 0.081 0.055
a One Way ANOVA.
Figure 1 Loss and gain of distance CDVA at 3 months
postoperatively, with close proximity of gain and loss of line of
CDVA between the groups. The ﬂap-off group showed slightly
more of one line gain and no losses.
Figure 2 Uncorrected distance visual acuity at 3 months post-
operatively, with close proximity of achieved uncorrected visual
acuity between the groups at 20/20 level. At 20/12.5 iLASIK was
more effective.
278 T. AlMahmoud et al.surgery for HOA, SA and coma (0.371, P< 0.0001),
(0.309, P= 0.0007) and (0.182, P= 0.049). No signiﬁcant
correlations were identiﬁed for the iLASIK and only a signif-icant correlation for ﬂap-on group for ocular HOA (0.079,
P= 0.039).
4. Discussion
The results of this study as well as those reported by other inves-
tigators indicate that the WF ASA and LASIK have excellent
efﬁcacy, predictability and safety proﬁle for correction of myo-
pia (Kulkamthorn et al., 2008; Partal and Manche, 2006; Slade
etal., 2009).Most of the studies comparing surface ablationwith
LASIK are conducted using mechanical microkeratomes rather
than the Femtosecond laser for ﬂap creation (Chung etal., 2006;
Hersh etal., 1998;McAlinden andMoore, 2010) or compare the
iLASIK to one of the ASA techniques rather than both ﬂap-on
and ﬂap-off procedures (Slade et al., 2009). Slade et al. (2009)
used the Alcon LADARVision 4000 CustomCornea excimer la-
ser and found that 88% of iLASIK vs. 48% for AA-PRK had
UDVA of 20/20 or better at 3 months, slightly different
than those in our current study (68% in iLASIK and 57% for
AA-PRK). In the same study they also found that 46%
of iLASIK eyes had 20/16 or better compared with 16% for
AA-PRK. We found 40% of eyes achieved 20/16 in iLASIK
as well as AA-PRK group and 46% in the total ASA group
(53% and 11% for ﬂap-on and ﬂap-off, respectively). These dif-
ferences were found to persist at 1-year follow-up (Wallau and
Campos, 2009).
The differences between our results and the ones obtained
by Slade et al. may be caused by a small sample size or lower
myopia treated by Slade et al. (50 eyes, max. SE treated
5.75 D). The other difference could be related to the excimer
laser platform used. However, similar to Slade et al. (2009) we
found an excellent safety proﬁle for both ASA and iLASIK
with no procedure having loss of two lines or more of CDVA.
Clinical experience and previously published research have
indicated that non-optimal postoperative visual outcomes after
refractive surgery are associated with an increase in ocular
(Moreno-Barriuso et al., 2001) or corneal aberrations (Apple-
gate et al., 2000). Nevertheless, the theoretical advantages of
the epithelial ﬂap repositioning on the photoablated stroma
and degree of importance of viability of epithelial cells have
not yet been studied well. While some had shown the advan-
tage of retaining epithelial ﬂaps in term of reduction of subep-
ithelial stromal (Javier et al., 2006) and corneal wound healing
response (Ma et al., 2003). There are others that demonstrated
that there was no signiﬁcant difference in HOAs between Epi-
LASIK and Epi-PRK eyes at any interval (Kalyvianaki et al.,
Table 2 Ocular aberration with 5.00 mm pupil.
HOA (lm) SA (lm) Coma (lm)
Flap-on (Epi-LASIK + LASEK), mean ± SD or median (50% CI) (N= 120)
Preop 0.154 (0.119; 0.186) 0.041 (0.007; 0.082) 0.083 (0.052; 0.117)
3 M postop 0.248 (0.180; 0.297) 0.157 (0.089; 0.225) 0.092 (0.067; 0.151)
Change [P value]a 0.078 (0.032; 0.143) [<0.001] 0.117 (0.050; 0.170) [<0.001] 0.013 (0.032; 0.063) [0.029]
Flap-oﬀ (Epi-PRK+AA-PRK), mean ± SD or median (50% CI) (N= 120)
Preop 0.159 (0.128; 0.197) 0.038 (0.000; 0.069) 0.091 (0.056; 0.138)
3 M postop 0.205 (0.153; 0.294) 0.150 (0.083; 0.199) 0.107 (0.061; 0.142)
Change [P value]a 0.066 (0.010; 0.100) [<0.001] 0.123 (0.047; 0.171) [<0.001] 0.005 (0.040; 0.065) [0.160*]
iLASIK, mean ± SD or median (50% CI) (N= 137)
Preop 0.143 (0.102; 0.192) 0.039 (0.009; 0.082) 0.092 (0.057; 0.150)
3 M postop 0.148 (0.103; 0.222) 0.154 (0.087; 0.209) 0.113 (0.067; 0.162)
Change [P value]a 0.017 (0.040; 0.066) [0.227*] 0.048 (0.004; 0.085) [<0.001] 0.020 (0.035; 0.065) [0.052*]
N= total number of eyes in that group.
a Paired t-test or Signed Rank test.
* No signiﬁcant change following surgery.
Table 3 Corneal aberration with 5.00 mm pupil.
HOA (lm) SA (lm) Coma (lm)
Flap-on (Epi-LASIK + LASEK), mean ± SD or median (50% CI) (N= 120)
Preop 0.372 (0.292; 0.472) 0.195 (0.140; 0.252) 0.202 (0.117; 0.312)
3 M postop 0.538 (0.455; 0.670) 0.326 (0.223; 0.424) 0.230 (0.135; 0.349)
Change [P value]a 0.161 (0.046; 0.306) [<0.001] 0.134 (0.033; 0.218) [<0.001] 0.019 (0.042; 0.093) [0.178*]
Flap-oﬀ (Epi-PRK+AA-PRK), mean ± SD or median (50% CI) (N= 120)
Preop 0.342 (0.302; 0.404) 0.162 (0.118; 0.209) 0.201 (0.137; 0.276)
3 M postop 0.541 (0.430; 0.660) 0.315 (0.222; 0.428) 0.265 (0.162; 0.364)
Change [P value]a 0.198 (0.075; 0.323) [<0.001] 0.150 (0.069; 0.274) [<0.001] 0.046 (0.032; 0.158) [<0.001]
iLASIK, mean ± SD or median (50% CI) (N= 137)
Preop 0.214 (0.164; 0.275) 0.223 (0.170; 0.270) 0.140 (0.083; 0.212)
3 M postop 0.316 (0.244; 0.393) 0.328 (0.242; 0.441) 0.200 (0.139; 0.281)
Change [P value]a 0.102 (0.015; 0.192) [<0.001] 0.118 (0.032; 0.209) [<0.001] 0.065 (0.032; 0.159) [<0.001]
N= number of eyes in that group.
a Paired t-test or Signed ranked test.
* No signiﬁcant change following surgery.
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er increase in ocular and corneal aberrations compared with
the ﬂap-on, however the UDVA of 20/20 were very close
(70% vs. 67%) but dissimilar outcomes for uncorrected visual
acuity at 20/16 or better (53% vs. 11%) were noticed. This may
suggest some differences in the postoperative corneal wound
healing response between procedures which may not have been
stabilized by 3 months.
Some had documented that there is a statistically signiﬁcant
correlation between ocular wavefront error and CDVA in PRK
(Seiler et al., 2000). In the present study, only the ﬂap-off treat-
ment showed a consistent correlation between the corrected
aberrations and visual performance. This ﬁnding suggests that
postoperative changes in aberration contribute to the ﬁnal VA
outcome of WF ablation and modifying the existing ablation
pattern for the ﬂap-off ASA to compensate for induced HOAs
may that have the potential to improve the visual outcomes.
Slade et al. (2009) showed no statistical signiﬁcant differ-
ence for ocular HOAs, coma or SA between iLASIK and
AA-PRK at 3 months follow-up. It also have been noted that
corneal spherical-like aberrations are increased more inLASEK than after LASIK even with the same laser platform
(Buzzonetti et al., 2004). On the other hand, Wallau and Cam-
pos documented that total HOA and spherical aberration were
statistically signiﬁcantly higher in LASIK eyes than in the
MMC-PRK group during the 1-year follow-up (Wallau and
Campos, 2009). In our cohort, iLASIK induced lower corneal
and ocular HOA compared to either ﬂap-on or off groups. De-
spite that all procedure types induced signiﬁcant corneal aber-
rations; this was not directly proportional with increase in the
ocular aberrations, where we found that the induced ocular
aberrations were smaller than the corneal. This ﬁnding sug-
gests that postoperative ocular aberrations are compensated
by changes to the posterior cornea and or to the internal path-
way of light into the eye (Marcos, 2001). It also appears that in
iLASIK the corneal changes are minimal so that the compen-
sation mechanism is sufﬁcient to minimize the global ocular ef-
fect from the introduced changes on anterior corneal surface.
So, it is proposed that these differences are primarily due to
the method of ﬂap creation (McAlinden and Moore, 2010;
Tran et al., 2005); hence, the creation of stromal ﬂap by itself
may modify HOAs in a different manner than ASA which
280 T. AlMahmoud et al.provoke greater wound remodeling response. These may also
indicate that placing the ablation under a thin planar iLASIK
ﬂap may account for less induced aberrations, specially that
corneal wound healing response after PRK has been found
to be greater and longer than after LASIK (Ma et al., 2003).
In addition, wound healing may not have stabilized at
3 months for ASA resulting in higher aberrations than might
be present with a longer follow-up. Also as seen in other pub-
lished comparisons, by the third postoperative month, the dif-
ference between the two groups begin to equalize and by
6 month there is no statistical difference between the groups
(Slade et al., 2009). Further investigations with longer fol-
low-up periods are warranted.
5. Conclusion
ASA techniques and iLASIK are safe and effective in treating
myopia. All procedures resulted in a signiﬁcant increase in
HOAs and SA and all had comparable 20/20 VA, while
iLASIK was more effective at 20/12.5 or better level. The
ﬂap-off treatment showed a signiﬁcant negative correlation be-
tween the corrected aberrations and visual performance (as
aberration decreased, CDVA increases) postoperatively, indi-
cating that modifying the existing ablation pattern for this
technique to compensate for induced HOAs may have the
potential to improve the visual outcomes.
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